• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配制基础:实施美国药典第797章药物配制-无菌制剂的考虑因素,第7部分:微生物污染风险水平、12小时使用和立即使用。

Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use.

作者信息

Allen Loyd V, Okeke Claudia C

机构信息

International Journal of Pharmaceutical Compounding, Edmond, Oklahoma.

出版信息

Int J Pharm Compd. 2008 May-Jun;12(3):252-7.

PMID:23969716
Abstract

This article discusses the types of contamination that may occur when compounding personnel prepare, handle, or store sterile preparations, as discussed in United States Pharmacopeia Chapter 797 Pharmaceutical Compounding-Sterile Preparations. Contamination may be microbial, physical, or chemical, and all these are possible when sterile preparations are made. Microbial contamination may be fungal or bacterial. The most frequently identified microbial organisms in sterile preparations are spores and endotoxins. Chemical and physical contamination includes foreign objects, chemicals, physical matter, nonsterile components or objects, and airborne particles, objects, or matter from environments with uncontrolled air quality. Thorough knowledge of the possible sources of contamination can help in implementing the steps and processes to avoid contamination. The purpose of this article is to review the contamination risk level categories as disussed in Chapter 797.

摘要

本文讨论了在调配人员制备、处理或储存无菌制剂时可能发生的污染类型,如《美国药典》第797章“药物调配 - 无菌制剂”中所述。污染可能是微生物、物理或化学污染,而在制备无菌制剂时所有这些污染都有可能发生。微生物污染可能是真菌或细菌污染。无菌制剂中最常发现的微生物是孢子和内毒素。化学和物理污染包括异物、化学物质、物理物质、非无菌成分或物品,以及来自空气质量未得到控制的环境中的空气传播颗粒、物品或物质。全面了解可能的污染源有助于实施避免污染的步骤和流程。本文的目的是回顾第797章中讨论的污染风险水平类别。

相似文献

1
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 7: microbial contamination risk levels, 12-hour use, and immediate use.配制基础:实施美国药典第797章药物配制-无菌制剂的考虑因素,第7部分:微生物污染风险水平、12小时使用和立即使用。
Int J Pharm Compd. 2008 May-Jun;12(3):252-7.
2
Basics of compounding; considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13.配制基础;实施美国药典第797章《药物配制-无菌制剂》第13部分的注意事项。
Int J Pharm Compd. 2009 May-Jun;13(3):234-8.
3
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第15部分:人员培训、清洁与着装
Int J Pharm Compd. 2009 Sep-Oct;11(5):420-6.
4
Basics of compounding: application of the United States pharmacopeia bacterial endotoxins test to compounded sterile preparations.配制基础:美国药典细菌内毒素检测在无菌配制制剂中的应用。
Int J Pharm Compd. 2006 Jan-Feb;10:36-9.
5
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第8部分:稳定性和使用期限
Int J Pharm Compd. 2008 Jul-Aug;12(4):344-53.
6
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.配制基础:实施美国药典第797章药物配制-无菌制剂的注意事项,第4部分:消毒剂和防腐剂选择与使用的注意事项
Int J Pharm Compd. 2007 Nov-Dec;11(6):492-9.
7
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 14: environmental quality and control (continued).配制基础:实施美国药典第797章《药物配制 - 无菌制剂》第14部分:环境质量与控制的注意事项(续)
Int J Pharm Compd. 2009 Jul-Aug;13(4):322-9.
8
Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparation, part 3: risk levels.
Int J Pharm Compd. 2007 Sep-Oct;11(5):404-10.
9
Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding sterile preparations, part 6: 2008 revisions to chapter 797.配制基础:实施美国药典第797章无菌药物制剂配制的注意事项,第6部分:2008年对第797章的修订
Int J Pharm Compd. 2008 Mar-Apr;12(2):136-44.
10
Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 9: immediate use compounded sterile preparations.实施美国药典第797章药品配制-无菌制剂,第9部分:立即使用的配制无菌制剂的注意事项。
Int J Pharm Compd. 2008 Sep-Oct;12(5):440-3.